Company Filing History:
Years Active: 2014
Title: Wolfgang Garten: Innovator in Therapeutic Peptide Derivatives
Introduction
Wolfgang Garten is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of therapeutic peptide derivatives, particularly in the development of innovative compounds aimed at combating various diseases.
Latest Patents
Garten holds a patent for "N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic." This invention pertains to multibasic, N-terminally modified tetrapeptide mimetics that include a C-terminal P1-arginine mimetic. The methods for their production and application are designed for the therapy and prophylaxis of diseases caused by bacterial pathogens or viruses. Additionally, these compounds are intended for the treatment and prevention of diabetes, arteriosclerosis, cancer, Alzheimer's disease, and obesity. The patent also highlights the use of these compounds as inhibitors of proprotein convertases, particularly for inhibiting the protease furin.
Career Highlights
Garten is affiliated with Philipps-Universität Marburg, where he continues to engage in research and development in the field of peptide therapeutics. His work has garnered attention for its potential impact on medical treatments.
Collaborations
Some of Wolfgang Garten's notable collaborators include Torsten Steinmetzer and Gero Becker. Their combined expertise contributes to the advancement of research in therapeutic applications.
Conclusion
Wolfgang Garten's innovative work in peptide derivatives showcases his commitment to addressing critical health challenges through scientific research and development. His contributions are paving the way for new therapeutic options in medicine.